Home> Products> managing major depressive disorder

{ "products": [ { "_id": "694d14f6274fc8b97e9b7120", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Mirtazapine 30mg", "description": "MIRTAZPRIME 30 is a pharmaceutical formulation containing Mirtazapine 30mg as per Indian Pharmacopoeia (IP) standards. This prescription medication belongs to a class of drugs known as tetracyclic antidepressants and represents an advanced therapeutic option for individuals struggling with major depressive disorder and related mental health conditions. Manufactured under stringent quality control measures, MIRTAZPRIME 30 offers patients a reliable and effective solution for managing depression while also addressing associated symptoms such as insomnia and anxiety.\nMirtazapine, the active pharmaceutical ingredient in MIRTAZPRIME 30, works through a unique dual mechanism that distinguishes it from other antidepressants. Unlike selective serotonin reuptake inhibitors (SSRIs), mirtazapine enhances the release of both norepinephrine and serotonin in the brain by blocking specific receptors. This innovative approach not only helps alleviate depressive symptoms but also provides sedative effects that can be particularly beneficial for patients experiencing sleep disturbances alongside depression.\nTherapeutic Uses and Applications\nMIRTAZPRIME 30 is primarily indicated for the treatment of major depressive disorder (MDD), a serious mental health condition characterized by persistent feelings of sadness, hopelessness, and loss of interest in daily activities. The medication has demonstrated significant efficacy in clinical trials, showing improvement in mood, energy levels, and overall quality of life for patients suffering from depression.\nBeyond its primary indication, healthcare providers may prescribe MIRTAZPRIME 30 for various off-label uses based on clinical judgment and patient needs. The medication has shown promise in managing generalized anxiety disorder, where excessive worry and tension interfere with daily functioning. Its sedative properties make it particularly valuable for patients experiencing insomnia related to depression or anxiety, as it can help restore healthy sleep patterns without the need for additional sleep medications.\nThe 30mg dosage strength represents a therapeutic level commonly prescribed for maintenance treatment after initial dose titration. Patients typically begin with lower doses and gradually increase to 30mg as their body adjusts to the medication and their symptoms require more robust management. This dosage provides an optimal balance between therapeutic efficacy and side effect management for many individuals.\nMIRTAZPRIME 30 may also be considered for patients who have not responded adequately to other antidepressant therapies, offering an alternative mechanism of action that can break through treatment-resistant depression. Additionally, its appetite-stimulating effects can be beneficial for patients experiencing significant weight loss due to depression or other medical conditions.\nKey Benefits and Therapeutic Advantages\nThe benefits of MIRTAZPRIME 30 extend beyond simple symptom relief, offering patients a multifaceted approach to mental health recovery. One of the most significant advantages is its relatively rapid onset of action compared to many other antidepressants. While most SSRIs require several weeks to demonstrate meaningful clinical improvement, patients taking mirtazapine often experience some relief from symptoms within one to two weeks, with continued improvement over subsequent weeks.\nThe dual neurotransmitter action of MIRTAZPRIME 30 provides comprehensive coverage of depressive symptoms. By enhancing both serotonergic and noradrenergic neurotransmission, the medication addresses the complex neurochemical imbalances underlying depression more thoroughly than single-mechanism antidepressants. This broader action can result in more complete symptom resolution and better overall outcomes.\nSleep improvement represents another crucial benefit of MIRTAZPRIME 30. The medication's sedative properties, particularly pronounced at lower doses, help patients fall asleep faster and enjoy more restorative sleep throughout the night. This is especially valuable since sleep disturbances are both a symptom and an exacerbating factor in depression. Better sleep quality contributes to improved daytime functioning, energy levels, and emotional regulation.\nUnlike many antidepressants that commonly cause sexual dysfunction, MIRTAZPRIME 30 has a relatively favorable profile in this regard. The medication is less likely to interfere with sexual function, making it an attractive option for patients who have experienced these troublesome side effects with other antidepressants. This characteristic can significantly improve treatment adherence and quality of life.\nThe appetite-stimulating effect, while considered a side effect by some, can be therapeutically beneficial for patients experiencing significant weight loss or poor appetite due to depression. MIRTAZPRIME 30 can help restore healthy eating patterns and reverse the physical decline that often accompanies severe depressive episodes.\nFurthermore, MIRTAZPRIME 30 does not typically cause the gastrointestinal side effects commonly associated with SSRI antidepressants, such as nausea, diarrhea, or stomach upset. This improved gastrointestinal tolerability enhances patient comfort and compliance with treatment regimens.\nPotential Side Effects and Safety Considerations\nWhile MIRTAZPRIME 30 offers numerous therapeutic benefits, patients should be aware of potential side effects that may occur during treatment. Understanding these effects helps patients make informed decisions and enables early identification of any concerning symptoms requiring medical attention.\nThe most commonly reported side effect is drowsiness or sedation, particularly during the initial weeks of treatment. This effect is typically most pronounced during the first few hours after taking the medication, which is why it's generally recommended for evening administration. Patients should exercise caution when driving, operating machinery, or engaging in activities requiring alertness until they understand how the medication affects them personally.\nIncreased appetite and weight gain represent another frequent side effect of MIRTAZPRIME 30. While beneficial for some patients, others may find this effect undesirable. Weight gain typically ranges from moderate to significant and appears to be dose-related. Patients concerned about weight should discuss dietary strategies and exercise plans with their healthcare provider.\nDry mouth is a common anticholinergic side effect that can cause discomfort but is generally manageable through increased fluid intake, sugar-free gum or candy, and good oral hygiene practices. Some patients may also experience dizziness, particularly when standing up quickly, due to the medication's effects on blood pressure regulation.\nConstipation may occur in some patients and can usually be managed through dietary modifications, increased fiber intake, adequate hydration, and regular physical activity. Less commonly, patients might experience confusion, abnormal dreams, or changes in thinking, particularly in older adults who may be more sensitive to the medication's effects.\nSerious side effects, while rare, require immediate medical attention. These include signs of allergic reactions such as rash, itching, swelling, severe dizziness, or difficulty breathing. Agranulocytosis, a dangerous decrease in white blood cells, is an extremely rare but serious complication that manifests as fever, sore throat, or signs of infection. Any unexplained fever or signs of infection should prompt immediate contact with a healthcare provider.\nSerotonin syndrome is another rare but potentially life-threatening condition that can occur when mirtazapine is combined with other medications affecting serotonin levels. Symptoms include agitation, hallucinations, rapid heartbeat, fever, excessive sweating, muscle stiffness, or coordination problems. Patients should inform their healthcare provider about all medications and supplements they are taking to avoid dangerous interactions.\nAbrupt discontinuation of MIRTAZPRIME 30 can lead to withdrawal symptoms, including nausea, anxiety, irritability, and flu-like symptoms. Therefore, any decision to stop the medication should be made in consultation with a healthcare provider who can develop an appropriate tapering schedule.\nImportant Usage Guidelines\nMIRTAZPRIME 30 should always be taken exactly as prescribed by a qualified healthcare professional. The medication is typically administered once daily, preferably in the evening before bedtime due to its sedative effects. Tablets should be swallowed whole with water and can be taken with or without food, though taking them with food may help reduce any stomach upset.\nConsistency in timing is important for maintaining stable blood levels of the medication and optimizing therapeutic effects. Patients should try to take their dose at approximately the same time each evening. If a dose is missed, it should be taken as soon as remembered unless it's close to the time for the next scheduled dose, in which case the missed dose should be skipped rather than doubling up.\nThe full therapeutic benefits of MIRTAZPRIME 30 may take several weeks to manifest. Patients should continue taking the medication as prescribed even if they don't feel immediate improvement. Premature discontinuation is a common reason for treatment failure in depression management.\nRegular follow-up appointments with the prescribing physician are essential for monitoring treatment response, adjusting dosages if necessary, and screening for potential side effects. Patients should maintain open communication with their healthcare team about their symptoms, concerns, and any changes in their condition.\nConclusion\nMIRTAZPRIME 30 represents a valuable therapeutic option in the comprehensive management of major depressive disorder and related conditions. Its unique mechanism of action, combining enhanced noradrenergic and serotonergic neurotransmission with sedative and appetite-stimulating properties, offers distinct advantages for carefully selected patients. The medication's ability to improve both mood symptoms and sleep disturbances makes it particularly useful for patients experiencing depression accompanied by insomnia.\nThe relatively favorable side effect profile, particularly regarding sexual function and gastrointestinal tolerability, enhances patient acceptance and adherence to treatment. While potential side effects such as sedation, increased appetite, and weight gain require monitoring and management, many patients find these effects tolerable compared to the debilitating symptoms of untreated depression.\nSuccess with MIRTAZPRIME 30, as with any antidepressant therapy, depends on proper patient selection, appropriate dosing, regular monitoring, and a comprehensive treatment approach that may include psychotherapy, lifestyle modifications, and social support alongside pharmacological intervention. Patients should work closely with their healthcare providers to optimize treatment outcomes and maintain long-term mental health wellness.\nThe decision to use MIRTAZPRIME 30 should always be made collaboratively between patient and physician, considering individual symptoms, treatment history, coexisting medical conditions, and personal preferences. With proper use under medical supervision, MIRTAZPRIME 30 can be an effective tool in helping patients reclaim their lives from the devastating effects of depression and move toward recovery and renewed well-being.", "price": 262.0, "discountamount": 79.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2254, "imageuri": "https://productimages.withfloats.com/actual/694d14f83d39ca31a28d046b.png", "tileimageuri": "https://productimages.withfloats.com/tile/694d14f83d39ca31a28d046b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-25T10:41:58.966Z", "updatedon": "2026-03-13T07:46:51.004Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mirtazapine-30mg/2254", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MIRTAZPRIME 30", "category": "NEUROLOGYRANGE", "tags": [ "MIRTAZPRIME 30", "Mirtazapine 30mg as per Indian Pharmacopoeia (IP) standards", "managing depression", "insomnia and anxiety.", "depression or anxiety.", "depredepressive episodes.", "helping patients reclaim their lives from the devastating effects of depression." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "666c10e66641561b0446977f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "VELAXFINE XR 37.5 ", "description": "VELAXFINE XR 37.5 \nVenlafaxine (37.5mg)\nIntroduction:\n\nVELAXFINE XR 37.5 contains Venlafaxine, an extended-release (XR) formulation designed to treat major depressive disorder (MDD), generalized anxiety disorder (GAD), social anxiety disorder (SAD), and panic disorder. With a dosage strength of 37.5mg, VELAXFINE XR 37.5 provides sustained therapeutic effects, significantly improving the quality of life for patients.\nKey Features and Benefits:\n\nAntidepressant Action:\n\nVELAXFINE XR 37.5 is a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by increasing the levels of serotonin and norepinephrine in the brain, which helps improve mood and alleviate symptoms of depression.\nAnxiety Relief:\n\nVenlafaxine is effective in treating various anxiety disorders. It reduces the symptoms of anxiety, including excessive worry, restlessness, and physical symptoms such as palpitations and sweating.\nExtended-Release Formulation:\n\nThe extended-release formulation ensures a steady release of medication over 24 hours, providing consistent symptom relief and reducing the need for multiple daily doses. This improves adherence to the treatment regimen and enhances overall effectiveness.\nImproved Quality of Life:\n\nBy effectively managing symptoms of depression and anxiety, VELAXFINE XR 37.5 helps patients regain control of their lives, enhancing their ability to function socially and professionally.\nWell-Tolerated and Safe:\n\nVELAXFINE XR 37.5 is generally well-tolerated with a favorable safety profile, making it a reliable option for long-term management of depression and anxiety disorders.\nDosage and Administration:\n\nInitial Dosage for Depression and Anxiety:\n\nThe recommended starting dose of VELAXFINE XR 37.5 for adults is 37.5mg once daily, taken in the morning or evening. The dose may be increased gradually based on the patient's response and tolerability.\nMaintenance Dosage:\n\nThe usual maintenance dose ranges from 75mg to 225mg per day. Dosage adjustments should be made in increments of 37.5mg to 75mg at intervals of no less than 4 days.\nAdministration Instructions:\n\nVELAXFINE XR 37.5 capsules should be swallowed whole with water. They can be taken with or without food, although taking them with food may help reduce gastrointestinal discomfort.\nContinued Monitoring:\n\nRegular monitoring of symptoms, response to treatment, and potential side effects is essential during VELAXFINE XR 37.5 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 54.0, "discountamount": 16.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "MDD", "SAD", "day", "GAD", "food", "life", "SNRI", "mood", "75mg", "need", "EMAIL", "water", "brain", "lives", "225mg", "37.5mg", "levels", "adults", "option", "control", "ability", "evening", "morning", "response", "patients", "Benefits", "sweating", "24 hours", "adherence", "intervals", "increments", "medication", "depression", "Venlafaxine", "information", "restlessness", "palpitations", "sterispharma", "sterisonline", "Introduction", "Key Features", "CALL/WHATSAPP", "starting dose", "panic disorder", "Initial Dosage", "patient safety", "steady release", "Anxiety Relief", "excessive worry", "dosage strength", "Improved Quality", "physical symptoms", "treatment regimen", "Regular monitoring", "Dosage adjustments", "Maintenance Dosage", "therapeutic efficacy", "Continued Monitoring", "multiple daily doses", "long-term management", "Antidepressant Action", "overall effectiveness", "usual maintenance dose", "potential side effects", "social anxiety disorder", "favorable safety profile", "VELAXFINE XR 37.5 therapy", "various anxiety disorders", "consistent symptom relief", "major depressive disorder", "VELAXFINE XR 37.5 capsules", "gastrointestinal discomfort", "Administration Instructions", "Extended-Release Formulation", "generalized anxiety disorder", "sustained therapeutic effects", "serotonin-norepinephrine reuptake inhibitor" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1910, "imageuri": "https://productimages.withfloats.com/actual/667d14c6ba7e6420d2a4fd30.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d14c6ba7e6420d2a4fd30.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T09:44:06.065Z", "updatedon": "2026-03-13T05:51:43.936Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//velaxfine-xr-37-5-/1910", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "VELAXFINE XR 37.5 ", "category": "NEUROLOGY RANGE", "tags": [ "venlafaxine 37.5 mg", "VELAXFINE XR 37.5", "", "VELAXFINE XR 37.5 side effects", "venlafaxine 37.5mg used for", "venlafaxine urinary side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666ae3f4b453b6167c50636f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "QT-PINE 50 ", "description": "QT-PINE 50 \nQuetiapine (50mg)\nIntroduction:\nQT-PINE 50 encapsulates the therapeutic prowess of Quetiapine, an esteemed atypical antipsychotic renowned for its efficacy in managing a spectrum of psychiatric conditions. With a dosage strength of 50mg, QT-PINE 50 aims to harmonize mental health by addressing specific symptoms and promoting stability.\nKey Features and Benefits:\n\nAntipsychotic Efficacy:\n\nQuetiapine, the cornerstone of QT-PINE 50, exerts its antipsychotic effects by modulating dopamine and serotonin receptors, alleviating symptoms like hallucinations, delusions, and cognitive distortions in conditions such as schizophrenia.\nMood Stabilization:\n\nQT-PINE 50 aids in stabilizing mood fluctuations associated with bipolar disorder, helping to mitigate manic and depressive episodes and fostering emotional equilibrium.\nDepression Management:\n\nBeyond its antipsychotic properties, Quetiapine in QT-PINE 50 exhibits antidepressant effects by enhancing serotonin and norepinephrine activity, making it beneficial for individuals grappling with major depressive disorder (MDD).\nAnxiolytic Support:\n\nQT-PINE 50's anxiolytic attributes contribute to reducing anxiety symptoms prevalent in generalized anxiety disorder (GAD) and social anxiety disorder (SAD), promoting a sense of calmness and composure.\nDosage and Administration:\n\nInitiation and Adjustment:\nThe recommended starting dose of QT-PINE 50 is 50mg administered orally once daily. Dosage adjustments should be made judiciously under medical supervision based on individual response and tolerability.\nAdministration Guidance:\nQT-PINE 50 tablets should be swallowed whole with water, not crushed or chewed, and taken consistently at the same time daily for optimal therapeutic outcomes.\nTreatment Duration:\nContinuation of QT-PINE 50 should align with healthcare provider recommendations, even if symptom improvement is noted, to sustain therapeutic benefits and prevent relapse.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW .", "price": 51.0, "discountamount": 15.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "SAD", "GAD", "MDD", "50mg", "EMAIL", "manic", "sense", "water", "product", "relapse", "dopamine", "spectrum", "calmness", "delusions", "composure", "stability", "same time", "Initiation", "Quetiapine", "individuals", "cornerstone", "information", "Introduction", "sterisonline", "sterispharma", "Continuation", "tolerability", "Key Features", "schizophrenia", "mental health", "starting dose", "CALL/WHATSAPP", "hallucinations", "dosage strength", "QT-PINE 50 aids", "bipolar disorder", "anxiety symptoms", "specific symptoms", "mood fluctuations", "Treatment Duration", "Dosage adjustments", "Anxiolytic Support", "Mood Stabilization", "QT-PINE 50 tablets", "serotonin receptors", "therapeutic prowess", "depressive episodes", "symptom improvement", "individual response", "medical supervision", "therapeutic benefits", "antipsychotic effects", "anxiolytic attributes", "Depression Management", "emotional equilibrium", "cognitive distortions", "psychiatric conditions", "Antipsychotic Efficacy", "antidepressant effects", "atypical antipsychotic", "norepinephrine activity", "social anxiety disorder", "Administration Guidance", "antipsychotic properties", "major depressive disorder", "optimal therapeutic outcomes", "generalized anxiety disorder", "healthcare provider recommendations" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1886, "imageuri": "https://productimages.withfloats.com/actual/667d1603c134db5b38ba48f4.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d1603c134db5b38ba48f4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T12:20:04.778Z", "updatedon": "2026-03-14T10:28:17.931Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//qt-pine-50-/1886", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "QT-PINE 50 ", "category": "NEUROLOGY RANGE", "tags": [ "quetiapine 50 mg uses", "quetiapine side effects", "QT-PINE 50", "", "quetiapine for sleep", "quetiapine for sleep side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666ae2d4ca84cd189c25cb49", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "QT-PINE 25", "description": "QT-PINE 25 \nQuetiapine (25mg)\nIntroduction:\n\nQT-PINE 25 contains Quetiapine, an atypical antipsychotic medication renowned for its efficacy in managing various psychiatric conditions. With a dosage strength of 25mg, QT-PINE 25 is designed to address specific mental health needs with precision and effectiveness.\nKey Features and Benefits:\n\nAntipsychotic Properties:\n\nQuetiapine in QT-PINE 25 acts on dopamine and serotonin receptors in the brain, alleviating symptoms of schizophrenia such as hallucinations, delusions, and thought disorders.\nMood Stabilization:\n\nQT-PINE 25 is beneficial in stabilizing mood swings associated with bipolar disorder, preventing episodes of mania and depression. It helps maintain emotional balance and improves overall well-being.\nAntidepressant Effects:\n\nIn addition to its antipsychotic properties, Quetiapine in QT-PINE 25 exhibits antidepressant effects by modulating serotonin and norepinephrine levels. This makes it a valuable option for individuals with major depressive disorder (MDD).\nAnxiolytic Action:\n\nQT-PINE 25's anxiolytic properties contribute to reducing anxiety symptoms in conditions such as generalized anxiety disorder (GAD) and social anxiety disorder (SAD), promoting a calmer mental state.\nDosage and Administration:\n\nStarting Dosage and Titration:\nThe initial recommended dose of QT-PINE 25 is 25mg taken orally once daily. Dosage adjustments may be made by your healthcare provider based on response and tolerability.\nAdministration Guidelines:\nSwallow QT-PINE 25 tablets whole with water, without crushing or chewing them. Take it consistently at the same time each day for optimal results.\nDuration of Use:\nContinue using QT-PINE 25 as directed by your doctor, even if symptoms improve. Abrupt discontinuation can lead to relapse or withdrawal symptoms.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/qt-pine-25-133617", "price": 44.5, "discountamount": 13.35, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "MDD", "SAD", "Use", "GAD", "25mg", "EMAIL", "brain", "mania", "water", "doctor", "relapse", "Duration", "Benefits", "efficacy", "episodes", "addition", "response", "dopamine", "precision", "same time", "delusions", "Titration", "depression", "Quetiapine", "individuals", "information", "mood swings", "sterisonline", "sterispharma", "Key Features", "tolerability", "Introduction", "schizophrenia", "effectiveness", "CALL/WHATSAPP", "hallucinations", "QT-PINE 25 acts", "Starting Dosage", "dosage strength", "optimal results", "valuable option", "anxiety symptoms", "bipolar disorder", "thought disorders", "emotional balance", "Anxiolytic Action", "QT-PINE 25 tablets", "Mood Stabilization", "Dosage adjustments", "overall well-being", "serotonin receptors", "healthcare provider", "withdrawal symptoms", "calmer mental state", "anxiolytic properties", "norepinephrine levels", "Abrupt discontinuation", "Antidepressant Effects", "social anxiety disorder", "Antipsychotic Properties", "initial recommended dose", "major depressive disorder", "Administration Guidelines", "generalized anxiety disorder", "specific mental health needs", "various psychiatric conditions", "atypical antipsychotic medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1885, "imageuri": "https://productimages.withfloats.com/actual/666ae344475de163fe90f46c.png", "tileimageuri": "https://productimages.withfloats.com/tile/666ae344475de163fe90f46c.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T12:15:16.921Z", "updatedon": "2026-03-14T10:25:01.469Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//qt-pine-25/1885", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "QT-PINE 25 ", "category": "NEUROLOGY RANGE", "tags": [ "quetiapine for sleep side effects", "qutipin 25 uses in hindi", "qutipin 25 uses in english", "quetiapine for sleep dosage" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666ae20ef7438b1754ba11bd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "QT-PINE SR 300", "description": "QT-PINE SR 300 \nQuetiapine Prolonged Release (300mg)\nIntroduction:\n\nQT-PINE SR 300 is a medication formulated with Quetiapine in a prolonged-release format, specifically designed to provide sustained therapeutic benefits for individuals dealing with various psychiatric disorders. Quetiapine, an atypical antipsychotic, is renowned for its effectiveness in managing schizophrenia, bipolar disorder, major depressive disorder (MDD), and related conditions.\nKey Features and Benefits:\n\nExtended Release Mechanism:\n\nQT-PINE SR 300 employs a prolonged-release mechanism to deliver Quetiapine gradually over an extended period. This feature ensures a consistent therapeutic concentration in the bloodstream, reducing the need for frequent dosing and enhancing treatment compliance.\nAntipsychotic and Mood-Stabilizing Properties:\n\nQuetiapine, the active ingredient in QT-PINE SR 300, acts by blocking dopamine and serotonin receptors in the brain. This action helps alleviate psychotic symptoms like hallucinations and delusions in schizophrenia and stabilizes mood swings in bipolar disorder, preventing manic and depressive episodes.\nAntidepressant Effects:\nQT-PINE SR 300 is prescribed for major depressive disorder (MDD) due to Quetiapine's antidepressant properties. It modulates serotonin and norepinephrine levels, alleviating depressive symptoms and improving overall mood and well-being.\nAnxiolytic Action:\n\nThe anxiolytic (anxiety-reducing) effects of Quetiapine contribute to its efficacy in managing anxiety disorders such as generalized anxiety disorder (GAD) and social anxiety disorder (SAD).\nDosage and Administration:\n\nInitial Dosage and Adjustment:\nThe typical starting dose of QT-PINE SR 300 is 300mg taken orally once daily, preferably in the evening due to potential sedative effects. Dosage adjustments may be made by your healthcare provider based on individual response and tolerability.\nAdministration Instructions:\nSwallow the QT-PINE SR 300 tablet whole with water, without crushing or chewing it. Adhere strictly to the prescribed dosing schedule to maintain therapeutic blood levels.\nDuration of Treatment:\nContinue taking QT-PINE SR 300 as directed by your doctor, even if symptoms improve. Abrupt discontinuation can lead to relapse or withdrawal symptoms.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW.", "price": 182.0, "discountamount": 55.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "MDD", "GAD", "SAD", "need", "brain", "manic", "water", "300mg", "EMAIL", "doctor", "evening", "relapse", "Duration", "efficacy", "dopamine", "delusions", "medication", "qt-pine-sr", "well-being", "mood swings", "individuals", "information", "bloodstream", "sterispharma", "tolerability", "Introduction", "overall mood", "Key Features", "sterisonline", "effectiveness", "CALL/WHATSAPP", "schizophrenia", "hallucinations", "Initial Dosage", "extended period", "frequent dosing", "dosing schedule", "bipolar disorder", "active ingredient", "anxiety disorders", "Anxiolytic Action", "psychotic symptoms", "Dosage adjustments", "related conditions", "withdrawal symptoms", "serotonin receptors", "depressive episodes", "individual response", "healthcare provider", "depressive symptoms", "treatment compliance", "typical starting dose", "norepinephrine levels", "QT-PINE SR 300 tablet", "atypical antipsychotic", "Abrupt discontinuation", "Antidepressant Effects", "social anxiety disorder", "therapeutic blood levels", "prolonged-release format", "major depressive disorder", "antidepressant properties", "potential sedative effects", "Extended Release Mechanism", "Mood Stabilizing Properties", "Administration Instructions", "prolonged-release mechanism", "Quetiapine Prolonged Release", "generalized anxiety disorder", "various psychiatric disorders", "sustained therapeutic benefits", "consistent therapeutic concentration", "anxiolytic (anxiety-reducing) effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1884, "imageuri": "https://productimages.withfloats.com/actual/666ae213f068be46bdebab38.png", "tileimageuri": "https://productimages.withfloats.com/tile/666ae213f068be46bdebab38.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T12:11:58.983Z", "updatedon": "2026-05-09T06:33:55.502Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//qt-pine-sr-300/1884", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "QT-PINE SR 300 ", "category": "NEUROLOGY RANGE", "tags": [ "qutipin 300 side effects", "quetiapine for sleep dosage", "qutipin is dangerous", "qutipin 25 uses", "quetiapine for sleep reviews" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666ae115cee93a1bbc383b92", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "QT-PINE SR 200 ", "description": "QT-PINE SR 200 \nQuetiapine Prolonged Release 200mg\nIntroduction:\nQT-PINE SR 200 is a medication containing Quetiapine in a prolonged-release formulation, designed to provide sustained therapeutic effects for individuals with psychiatric disorders. Quetiapine is an atypical antipsychotic known for its efficacy in managing schizophrenia, bipolar disorder, major depressive disorder (MDD), and other psychiatric conditions.\nKey Features and Benefits:\nExtended Release Formulation:\nQT-PINE SR 200 delivers Quetiapine in a prolonged-release manner, ensuring a steady concentration of the medication in the blood over an extended period. This feature reduces the frequency of dosing and enhances treatment adherence.\nAntipsychotic and Mood-Stabilizing Actions:\nQuetiapine, the active ingredient in QT-PINE SR 200, acts by blocking dopamine and serotonin receptors in the brain, effectively reducing psychotic symptoms such as hallucinations and delusions in schizophrenia and bipolar disorder. It also helps stabilize mood swings in bipolar disorder, preventing manic and depressive episodes.\nAntidepressant Effects:\nQT-PINE SR 200 is prescribed for MDD, where it functions as an antidepressant by modulating serotonin and norepinephrine levels, alleviating depressive symptoms and improving overall well-being.\nAnxiolytic Properties:\nQuetiapine's anxiolytic properties contribute to its efficacy in managing anxiety disorders, including generalized anxiety disorder (GAD) and social anxiety disorder (SAD).\nDosage and Administration:\nInitial Dosage: The typical starting dose of QT-PINE SR 200 is 200mg taken orally once daily, usually in the evening due to its sedative effects. Dosage adjustments may be made by your healthcare provider based on individual response and tolerability.\nAdministration: Swallow the QT-PINE SR 200 tablet whole with water, without crushing or chewing it. Follow the prescribed dosing schedule strictly to maintain therapeutic blood levels.\nDuration of Treatment: Continue taking QT-PINE SR 200 as directed by your doctor, even if symptoms improve. Abruptly stopping the medication can lead to relapse or withdrawal symptoms.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW.\n", "price": 116.0, "discountamount": 35.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "MDD", "GAD", "SAD", "manic", "brain", "200mg", "EMAIL", "water", "doctor", "evening", "product", "relapse", "Duration", "efficacy", "Benefits", "dopamine", "frequency", "delusions", "medication", "qt-pine-sr", "mood swings", "information", "individuals", "sterispharma", "tolerability", "Key Features", "sterisonline", "Introduction", "CALL/WHATSAPP", "schizophrenia", "hallucinations", "Administration", "Initial Dosage", "release manner", "extended period", "bipolar disorder", "sedative effects", "anxiety disorders", "active ingredient", "overall well-being", "psychotic symptoms", "Dosage adjustments", "individual response", "depressive symptoms", "serotonin receptors", "depressive episodes", "healthcare provider", "treatment adherence", "withdrawal symptoms", "steady concentration", "QT-PINE SR 200 tablet", "Anxiolytic Properties", "norepinephrine levels", "psychiatric disorders", "typical starting dose", "atypical antipsychotic", "Antidepressant Effects", "social anxiety disorder", "therapeutic blood levels", "Mood Stabilizing Actions", "major depressive disorder", "prescribed dosing schedule", "Quetiapine Prolonged Release", "Extended Release Formulation", "generalized anxiety disorder", "other psychiatric conditions", "prolonged-release formulation", "sustained therapeutic effects" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1883, "imageuri": "https://productimages.withfloats.com/actual/666ae1184b514c761a318679.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666ae1184b514c761a318679.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T12:07:49.791Z", "updatedon": "2026-03-12T11:24:48.296Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//qt-pine-sr-200-/1883", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "QT-PINE SR 200 ", "category": "NEUROLOGY RANGE", "tags": [ "qutipin 200 uses", "quetiapine for sleep reviews", "qutipin 200 mg side effects", "quetiapine reviews for depression", "prolonged-release formulation." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666ae0731542dd108c562830", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "QT-PINE 100 ", "description": "QT-PINE 100 \nQuetiapine (100mg)\nIntroduction:\n\nQT-PINE 100 contains Quetiapine, an atypical antipsychotic medication widely prescribed for various mental health disorders. Quetiapine is known for its efficacy in treating conditions such as schizophrenia, bipolar disorder, and major depressive disorder.\n\nQT-PINE 100: Quetiapine (100mg) for Mental Health Disorders\n\nIntroduction:\n\nQT-PINE 100 contains Quetiapine, an atypical antipsychotic medication widely prescribed for various mental health disorders. Quetiapine is known for its efficacy in treating conditions such as schizophrenia, bipolar disorder, and major depressive disorder.\n\nKey Features and Benefits:\n\nAntipsychotic Action:\n\nQuetiapine exerts its therapeutic effects by blocking dopamine and serotonin receptors in the brain, helping to alleviate symptoms of psychosis, hallucinations, and delusions associated with schizophrenia and bipolar disorder.\nMood Stabilization:\n\nIn bipolar disorder, QT-PINE 100 helps stabilize mood swings, reducing manic episodes' severity and frequency and preventing depressive episodes.\nAntidepressant Properties:\n\nQT-PINE 100 is also prescribed for major depressive disorder (MDD), where it acts as an antidepressant by modulating serotonin and norepinephrine levels, improving mood and reducing depressive symptoms.\nAnxiety Management:\n\nQuetiapine's anxiolytic properties make it effective in managing anxiety disorders, including generalized anxiety disorder (GAD) and social anxiety disorder (SAD).\nDosage and Administration:\n\nStarting Dose: The initial dose of QT-PINE 100 for schizophrenia and bipolar disorder is usually 100mg taken orally once daily, with gradual dose adjustments as needed based on response and tolerability.\nAdministration: Swallow the tablet whole with water, preferably at bedtime or as directed by your healthcare provider. Do not crush, chew, or break the tablet.\nDuration of Treatment: Continue taking QT-PINE 100 as prescribed, even if symptoms improve. Abruptly stopping the medication can lead to withdrawal symptoms or relapse.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/qt-pine-100-133619", "price": 81.0, "discountamount": 24.3, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1882, "imageuri": "https://productimages.withfloats.com/actual/666ae076897f5154474a3b5c.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666ae076897f5154474a3b5c.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T12:05:07.354Z", "updatedon": "2026-03-14T10:28:06.147Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//qt-pine-100-/1882", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "QT-PINE 100 ", "category": "NEUROLOGY RANGE", "tags": [ "qutipin 100 mg side effects", "quetiapine reviews for depression", "quetiapine for depression dosage", "qutipin 200 uses in hindi" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666ad0711542dd108c562450", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PAROXTIME CR 25 ", "description": "PAROXTIME CR 25 \nParoxetine 25 mg\nIntroduction:\n\nPAROXTIME CR 25 contains Paroxetine (25 mg), a selective serotonin reuptake inhibitor (SSRI) used to treat major depressive disorder, generalized anxiety disorder, panic disorder, social anxiety disorder, and other mental health conditions. Paroxetine works by increasing the levels of serotonin in the brain, which helps improve mood and reduce anxiety.\nKey Features and Benefits:\n\nDepression Treatment: Paroxetine effectively treats symptoms of major depressive disorder, including persistent sadness, loss of interest in activities, and feelings of hopelessness.\nAnxiety Relief: It is beneficial for managing generalized anxiety disorder, social anxiety disorder, and panic disorder, helping to reduce symptoms such as excessive worry, fear, and panic attacks.\nControlled Release: The controlled-release formulation ensures a steady release of medication throughout the day, providing consistent symptom relief and reducing the risk of side effects.\nImproved Mood: By enhancing serotonin levels, Paroxetine helps improve mood, energy levels, and overall mental well-being.\nProven Efficacy: Paroxetine is a well-established SSRI with a strong track record of safety and effectiveness in treating various mental health conditions.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of PAROXTIME CR 25 is one tablet (25 mg) taken once daily, usually in the morning.\nMaintenance Dosage: The dosage may be adjusted by a healthcare provider based on the patient's response to treatment. The usual maintenance dose ranges from 25 mg to 62.5 mg per day.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Paroxetine at the same time each day to maintain consistent medication levels in the bloodstream.\nMissed Dose: If a dose is missed, take it as soon as you remember. If it is almost time for the next dose, skip the missed dose and continue with the regular schedule. Do not take a double dose to make up for a missed one.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/paroxtime-cr-25-134187", "price": 195.0, "discountamount": 58.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "mg", "day", "risk", "loss", "food", "fear", "SSRI", "EMAIL", "brain", "water", "safety", "patient", "morning", "interest", "feelings", "response", "symptoms", "Benefits", "same time", "next dose", "one tablet", "activities", "Paroxetine", "double dose", "bloodstream", "information", "PAROXTIME CR", "sterisonline", "side effects", "hopelessness", "Key Features", "sterispharma", "Introduction", "panic attacks", "CALL/WHATSAPP", "effectiveness", "Improved Mood", "energy levels", "Administration", "Initial Dosage", "Anxiety Relief", "panic disorder", "steady release", "Proven Efficacy", "excessive worry", "regular schedule", "serotonin levels", "persistent sadness", "Maintenance Dosage", "Controlled Release", "healthcare provider", "strong track record", "Depression Treatment", "typical starting dose", "usual maintenance dose", "social anxiety disorder", "overall mental well-being", "consistent symptom relief", "major depressive disorder", "consistent medication levels", "generalized anxiety disorder", "controlled-release formulation", "other mental health conditions", "various mental health conditions", "selective serotonin reuptake inhibitor" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1872, "imageuri": "https://productimages.withfloats.com/actual/666ad074c9162f54a158be4f.png", "tileimageuri": "https://productimages.withfloats.com/tile/666ad074c9162f54a158be4f.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T10:56:49.88Z", "updatedon": "2026-03-13T06:41:03.515Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//paroxtime-cr-25-/1872", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PAROXTIME CR 25 ", "category": "NEUROLOGY RANGE", "tags": [ "paroxetine 25 mg side effects", "PAROXTIME CR 25", "paroxetine side effects sexually", "paroxetine side effects long-term" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666acfbbb6d3f41940ea928f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Paroxetine 12.5 mg ", "description": "PAROXTIME CR 12.5 \nParoxetine 12.5 mg\nIntroduction:\n\nPAROXTIME CR 12.5 contains Paroxetine (12.5 mg), a selective serotonin reuptake inhibitor (SSRI) used to treat major depressive disorder, generalized anxiety disorder, panic disorder, social anxiety disorder, and other mental health conditions. Paroxetine works by increasing the levels of serotonin in the brain, which helps improve mood and reduce anxiety.\nKey Features and Benefits:\n\nDepression Treatment: Paroxetine effectively treats symptoms of major depressive disorder, including persistent sadness, loss of interest in activities, and feelings of hopelessness.\nAnxiety Relief: It is beneficial for managing generalized anxiety disorder, social anxiety disorder, and panic disorder, helping to reduce symptoms such as excessive worry, fear, and panic attacks.\nControlled Release: The controlled-release formulation ensures a steady release of medication throughout the day, providing consistent symptom relief and reducing the risk of side effects.\nImproved Mood: By enhancing serotonin levels, Paroxetine helps improve mood, energy levels, and overall mental well-being.\nProven Efficacy: Paroxetine is a well-established SSRI with a strong track record of safety and effectiveness in treating various mental health conditions.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 135.0, "discountamount": 40.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "loss", "SSRI", "risk", "fear", "EMAIL", "brain", "safety", "Benefits", "interest", "symptoms", "feelings", "activities", "medication", "Paroxetine", "information", "Introduction", "side effects", "Key Features", "hopelessness", "sterispharma", "PAROXTIME CR", "sterisonline", "effectiveness", "energy levels", "CALL/WHATSAPP", "Improved Mood", "panic attacks", "Anxiety Relief", "panic disorder", "steady release", "excessive worry", "Proven Efficacy", "serotonin levels", "Controlled Release", "persistent sadness", "strong track record", "Depression Treatment", "social anxiety disorder", "overall mental well-being", "consistent symptom relief", "major depressive disorder", "generalized anxiety disorder", "controlled-release formulation", "other mental health conditions", "various mental health conditions", "selective serotonin reuptake inhibitor" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1871, "imageuri": "https://productimages.withfloats.com/actual/666acfbec9162f54a158be0b.png", "tileimageuri": "https://productimages.withfloats.com/tile/666acfbec9162f54a158be0b.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T10:53:47.164Z", "updatedon": "2026-03-13T06:39:43.052Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM//paroxetine-12-5-mg-/1871", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PAROXTIME CR 12.5 ", "category": "NEUROLOGY RANGE", "tags": [ "paroxetine cr 12.5 uses in hindi", "paroxetine 12.5 mg side effects", "paroxetine 12.5 मिलीग्राम", "Paroxetine 12.5mg price", "social anxiety disorder.", "Controlled Release.", "panic attacks.", "social anxiety disorder.", "which helps improve mood and reduce anxiety.", "Paroxetine works by increasing the levels of serotonin in the brain." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }